Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Search of the Perfect Earn-Out

This article was originally published in Start Up

Executive Summary

The widening gap between expectations of pricing between the buyers and sellers of emerging medical technology companies has increased the number of earn-out transactions, all of which have been different and offered varying degrees of risk and reward. According to Richard Ferrari, a managing director of De Novo Ventures, earn-out transactions are complex and need careful consideration to ensure that they benefit both parties--a poorly structured deal can lead to opportunistic behavior by the acquirer. Ferrari discusses the four stages that define the structure of all earnout transactions

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel